{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:19:29Z","timestamp":1781878769351,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008255","name":"Mustafa Kemal \u00dcniversitesi","doi-asserted-by":"publisher","award":["1106 M 0107"],"award-info":[{"award-number":["1106 M 0107"]}],"id":[{"id":"10.13039\/501100008255","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Beta thalassemia major (\u03b2-TM) is a common cause of skeletal morbidity and is associated with increased bone fracture risk, particularly in inadequately transfused children. The aim of this study was to investigate some potential biochemical markers as possible early predictors of BMD variations in children with \u03b2-TM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study included 38 children with \u03b2-TM and 40 sex-age matched controls. All patients were subjected to BMD assessment by dual-energy X-ray absorptiometry (DEXA). Serum beta-crosslaps (beta-CTx), osteoprotegerin (OPG), receptor activator of nuclear factor-kappa B ligand (RANKL), urinary deoxypyridinoline (DPD) and ferritin levels were compared between the groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Serum OPG levels were significantly lower in thalassemic children than in controls. The mean ratio of RANKL\/OPG was significantly higher in the thalassemic patients than in the control group. Osteoporosis was detected in 10 (3 female and 7 male) of 38 patients (26.3%) according to the femur Z score and in 6 of them (4 male and 2 female) (15.8%) according to the spine Z score.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Serum OPG concentrations can be used as a biochemical marker in screening patients with beta-thalassemia major for the development of osteoporosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-022-01290-x","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T12:04:57Z","timestamp":1655726697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessment of biochemical bone markers of osteoporosis in children with thalassemia major"],"prefix":"10.1186","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3522-9406","authenticated-orcid":false,"given":"Tanju","family":"\u00c7elik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9079-4574","authenticated-orcid":false,"given":"\u00d6zlem","family":"Sang\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3842-8788","authenticated-orcid":false,"given":"\u015eule","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-2910","authenticated-orcid":false,"given":"Ali","family":"Balc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1004-8086","authenticated-orcid":false,"given":"Sedat","family":"Motor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"issue":"2","key":"1290_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF03345587","volume":"31","author":"A Al Gaudio","year":"2008","unstructured":"Al Gaudio A, Morabito N, Xourafa A, Macr\u00ec I, Meo A, Morgante S, et al. Bisphosphonates in the treatment of thalassemia-associated osteoporosis. J Endocrinol Investig. 2008;31(2):181\u20134.","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"1290_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3324\/haematol.2008.000893","volume":"94","author":"E Voskaridou","year":"2009","unstructured":"Voskaridou E, Christoulas D, Xirakia C, Varvagiannis K, Boutsikas G, Bilalis A, et al. Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration. Haematologica. 2009;94(5):725\u20138.","journal-title":"Haematologica"},{"issue":"2","key":"1290_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2141.2004.05143.x","volume":"127","author":"E Voskaridou","year":"2004","unstructured":"Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol. 2004;127(2):127\u201339.","journal-title":"Br J Haematol"},{"issue":"6","key":"1290_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.bone.2011.03.765","volume":"48","author":"EB Fung","year":"2011","unstructured":"Fung EB, Vichinsky EP, Kwiatkowski JL, Huang J, Bachrach LK, Sawyer AJ, et al. Characterization of low bone mass in young patients with thalassemia by DXA, pQCT and markers of bone turnover. Bone. 2011;48(6):1305\u201312.","journal-title":"Bone"},{"key":"1290_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1651-2227.1997.tb09019.x","volume":"86","author":"A Filosa","year":"1997","unstructured":"Filosa A, Di Maio S, Vocca S, Saviano A, Esposito G, Pagano L. Longitudinal monitoring of bone mineral density in thalassaemic patients. Genetic structure and osteoporosis. Acta Pediatr. 1997;86:342\u20136.","journal-title":"Acta Pediatr"},{"key":"1290_CR6","first-page":"300","volume":"8","author":"N Skordis","year":"2011","unstructured":"Skordis N, Toumba M. Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects. Pediatr Endocrinol Rev. 2011;8:300\u20136.","journal-title":"Pediatr Endocrinol Rev"},{"key":"1290_CR7","doi-asserted-by":"publisher","first-page":"537673","DOI":"10.4061\/2010\/537673","volume":"2010","author":"M Toumba","year":"2010","unstructured":"Toumba M, Skordis N. Osteoporosis syndrome in thalassaemia major: an overview. J Osteoporos. 2010;2010:537673.","journal-title":"J Osteoporos"},{"issue":"8","key":"1290_CR8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3109\/08820139.2010.498492","volume":"39","author":"H Salah","year":"2010","unstructured":"Salah H, Atfy M, Fathy A, Atfy M, Mansor H, Saeed J. The clinical significance of OPG\/sRANKL ratio in thalassemia patients suffering from osteopenia or osteoporosis in Egyptian patients. Immunol Investig. 2010;39(8):820\u201332.","journal-title":"Immunol Investig"},{"issue":"4","key":"1290_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10654-011-9555-8","volume":"26","author":"L J\u00f8rgensen","year":"2011","unstructured":"J\u00f8rgensen L, Hansen JB, Brox J, Mathiesen E, Vik A, Jacobsen BK. Serum osteoprotegerin levels are related to height loss: the Troms\u00f8 study. Eur J Epidemiol. 2011;26(4):305\u201312.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"1290_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1359\/jbmr.040113","volume":"19","author":"N Morabito","year":"2004","unstructured":"Morabito N, Gaudio A, Lasco A, et al. Osteoprotegerin and RANKL in the pathogenesis of thalassemia\u2013induced osteoporosis. J Bone Miner Res. 2004;19(5):722\u20137.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"1290_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/MPH.0000000000000040","volume":"35","author":"MA Ozdemir","year":"2013","unstructured":"Ozdemir MA, Yilmaz K, Abdulrezzak U, Muhtaroglu S, Patiroglu T, Karakukcu M, et al. The efficacy of vitamin K2 and calcitriol combination on thalassemic osteopathy. J Pediatr Hematol Oncol. 2013;35(8):623\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"1290_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13104-018-3616-y","volume":"11","author":"MA Alfaqih","year":"2018","unstructured":"Alfaqih MA, Bashir N, Saadeh R, Khader Y, Barqawi M, Alqudah S. Dysregulation of the RANKL\/RANK\/OPG axis in thalassemia intermedia patients. BMC Res Notes. 2018;11(1):534. https:\/\/doi.org\/10.1186\/s13104-018-3616-y PMID: 30064480; PMCID: PMC6069879.","journal-title":"BMC Res Notes"},{"issue":"11","key":"1290_CR13","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s00198-019-05077-5","volume":"30","author":"S Akhtar Ali","year":"2019","unstructured":"Akhtar Ali S, Kang H, Olney R, Ramos-Platt L, Ryabets-Lienhard A, Cheung C, et al. Evaluating RANKL and OPG levels in patients with Duchenne muscular dystrophy. Osteoporos Int. 2019;30(11):2283\u20138. https:\/\/doi.org\/10.1007\/s00198-019-05077-5 Epub 2019 Aug 7. PMID: 31392399.","journal-title":"Osteoporos Int"},{"issue":"10","key":"1290_CR14","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1177\/0961203319867129","volume":"28","author":"R Ali","year":"2019","unstructured":"Ali R, Hammad A, El-Nahrery E, Hamdy N, Elhawary AK, Eid R. Serum RANKL, osteoprotegerin (OPG) and RANKL\/OPG ratio in children with systemic lupus erythematosus. Lupus. 2019;28(10):1233\u201342. https:\/\/doi.org\/10.1177\/0961203319867129 Epub 2019 Aug 12. PMID: 31403902.","journal-title":"Lupus."},{"issue":"4","key":"1290_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/14397595.2018.1500736","volume":"29","author":"A Taylan","year":"2019","unstructured":"Taylan A, Birlik M, Kenar G, Toprak B, Gundogdu B, Gurler O, et al. Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: a potential multifaceted relationship between OPG\/RANKL\/TRAIL and Wnt inhibitors. Mod Rheumatol. 2019;29(4):619\u201324. https:\/\/doi.org\/10.1080\/14397595.2018.1500736 Epub 2018 Sep 25. PMID: 30001654.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"1290_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13052-019-0748-1","volume":"45","author":"P Karalazou","year":"2019","unstructured":"Karalazou P, Ntelios D, Chatzopoulou F, Fragou A, Taousani M, Mouzaki K, et al. OPG\/RANK\/RANKL signaling axis in patients with type I diabetes: associations with parathormone and vitamin D. Ital J Pediatr. 2019;45(1):161. https:\/\/doi.org\/10.1186\/s13052-019-0748-1 PMID: 31823791; PMCID: PMC6902340.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"1290_CR17","first-page":"17","volume":"51","author":"AC Pietrapertosa","year":"2009","unstructured":"Pietrapertosa AC, Minenna G, Colella SM, Santeramo TM, Renni R, D'Amore M. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major. Panminerva Med. 2009;51(1):17\u201323 PMID: 19352306.","journal-title":"Panminerva Med"},{"issue":"5","key":"1290_CR18","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.4317\/medoral.22128","volume":"22","author":"L Bagan","year":"2017","unstructured":"Bagan L, Jim\u00e9nez Y, Leopoldo M, Rubert A, Bagan J. Serum levels of RANKL and OPG, and the RANKL\/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: are they useful biomarkers for the advanced stages of osteonecrosis? Med Oral Patol Oral Cir Bucal. 2017;22(5):e542\u20137. https:\/\/doi.org\/10.4317\/medoral.22128 PMID: 28809381; PMCID: PMC5694175.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"4","key":"1290_CR19","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41390-020-01197-5","volume":"89","author":"D El Amrousy","year":"2021","unstructured":"El Amrousy D, El-Afify D, Shabana A. Relationship between bone turnover markers and oxidative stress in children with type 1 diabetes mellitus. Pediatr Res. 2021;89(4):878\u201381. https:\/\/doi.org\/10.1038\/s41390-020-01197-5 Epub 2020 Oct 10. PMID: 33038875.","journal-title":"Pediatr Res"},{"issue":"5","key":"1290_CR20","doi-asserted-by":"publisher","first-page":"382","DOI":"10.14740\/jocmr2970w","volume":"9","author":"KA Alswat","year":"2017","unstructured":"Alswat KA. Gender Disparities in Osteoporosis. J Clin Med Res. 2017;9(5):382\u20137. https:\/\/doi.org\/10.14740\/jocmr2970w.","journal-title":"J Clin Med Res"},{"issue":"Suppl 1","key":"1290_CR21","first-page":"116","volume":"6","author":"A Kyriakou","year":"2008","unstructured":"Kyriakou A, Savva SC, Savvides I, Pangalou E, Ioannou YS, Christou S, et al. Gender differences in the prevalence and severity of bone disease in thalassaemia. Pediatr Endocrinol Rev. 2008;6(Suppl 1):116\u201322 PMID: 19337164.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"7","key":"1290_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/08880010701533702","volume":"24","author":"AA Shamshirsaz","year":"2007","unstructured":"Shamshirsaz AA, Bekheirnia MR, Kamgar M, et al. Bone mineral density in Iranian adolescents and young adults with thalassemia major. Pediatr Hematol Oncol. 2007;24(7):469\u201379.","journal-title":"Pediatr Hematol Oncol"},{"key":"1290_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4274\/tod.galenos.2020.85520","volume":"26","author":"M B\u00fcy\u00fck\u015fim\u015fek","year":"2020","unstructured":"B\u00fcy\u00fck\u015fim\u015fek M, Ba\u015flam\u0131\u015fl\u0131 \u0130F. The relationship between Iron accumulation, vitamin D deficiency and bone mineral density in patients with thalassemia major, thalassemia intermedia and sickle cell. Turk J Osteoporos. 2020;26:121\u20136. https:\/\/doi.org\/10.4274\/tod.galenos.2020.85520.","journal-title":"Turk J Osteoporos"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01290-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-022-01290-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-022-01290-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T12:05:58Z","timestamp":1655726758000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-022-01290-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1290"],"URL":"https:\/\/doi.org\/10.1186\/s13052-022-01290-x","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"8 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the ethical committee of the University of Mustafa Kemal (Protocol number 2011\/12).All methods were carried out in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.Written informed consent was obtained from all participants or if participants are under 16, from a parent and\/or legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any individual person\u2019s data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}